With the “gym,” Insilico is now targeting other biotech and pharmaceutical companies, offering to train new AI models for ...

Speeding up drug discovery in the age of AI may come down to a concept that's comfortingly old-fashioned: Consulting a ...

In this week’s edition of The Prototype, we look at using AI to find new drugs, quantum biotechnology, the ROI of generative ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

This webinar explores how liver microphysiological systems support toxicology from early screening to species-specific risk ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

With Paris Fashion Week menswear heading into its final weekend, Hermès marked a transition as Véronique Nichanian presented ...

This was my process to retain Arcane's stylised shapes and painterly textures.

Some of Donald Trump’s handpicked appointees who have a say in his White House ballroom project asked questions Thursday ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

It achieves AI-driven generative design of the first permeable macrocyclic peptide with more than two polar or ionizable fragments. -- Surrogate assays are a breakthrough for AI model training. 1910 ...

Cambridge, Massachusetts, January 14, 2025 - Insilico Medicine (“Insilico”, HKEX:03696), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the ...